Suchergebnisse - "Chan, Henry Lik-Yuen"

PubPharm (22)

1

Drug-drug interactions between direct-acting antivirals and co-medications : a territory-wide cohort study

enthalten in: Hepatology international | 2022

von Hui, V. | Au, C. | Lam, A. | +6

2

Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study

enthalten in: Hepatology international | 2022

von Hui, V. | Au, C. | Lam, A. | +6

3

Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study

enthalten in: Hepatology international | 2022

von Hui, V. | Au, C. | Lam, A. | +6

4

Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study

enthalten in: Hepatology international | 2022

von Hui, V. | Au, C. | Lam, A. | +6

5

Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B

enthalten in: European journal of internal medicine | 2021

von Lee, H. | Chon, Y. | Kim, B. | +6

6

Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients

enthalten in: Journal of gastroenterology | 2020

von Liang, L. | Wong, V. | Toyoda, H. | +9

7

Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients

enthalten in: Journal of gastroenterology | 2020

von Liang, L. | Wong, V. | Toyoda, H. | +9

8

Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients

enthalten in: Journal of gastroenterology | 2020

von Liang, L. | Wong, V. | Toyoda, H. | +9

9

Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients

enthalten in: Journal of gastroenterology | 2020

von Liang, L. | Wong, V. | Toyoda, H. | +9

10

Unresolved issues of immune tolerance in chronic hepatitis B

enthalten in: Journal of gastroenterology | 2020

von Lee, H. | Chan, H.